Officer and Director Stock Grant

Cary J. Claiborne, Chief Executive Officer and Director of ADIAL PHARMACEUTICALS, INC. (ADIL), was granted 37,985 restricted shares of common stock on April 7, 2026. These shares vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control, provided Claiborne remains in service to the Issuer. The grant has a transaction price of $0.0 per share. Following this transaction, Claiborne beneficially owns 40,417 shares of common stock.